As of 2025-06-02, the Fair Value of Bridge Biotherapeutics Inc (288330.KQ) is -1,892.68 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 731.00 KRW, the upside of Bridge Biotherapeutics Inc is -358.92%.
With the market price of 731.00 KRW and our fair value calculation, Bridge Biotherapeutics Inc (288330.KQ) is not a good investment. Investing in 288330.KQ stocks now will result in a potential loss of 358.92%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -19,232.00 | -26,278.29 | -41,699.71 | -42,320.90 | -19,755.76 | -29,857.33 |
| YoY growth | -1,551.47% | -36.64% | -58.68% | -1.49% | 53.32% | -318.99% |
| Market Cap (mil) | 38,150.89 |
| P/E | |
| Forward P/E |
| EPS | -378.54 |
| Avg earnings growth rate | -318.99% |
| TTM earnings | -19,755.76 |